Re-Consent for Participants Turning 18 in Pediatric Clinical Trials
Re-Consent for Participants Turning 18 in Pediatric Clinical Trials Managing Re-Consent for Participants Turning 18 in Pediatric Trials In pediatric clinical trials, participants initially provide assent, while legal guardians give informed consent. However, when a participant reaches the age of majority—typically 18 years—they must provide their own informed consent to continue in the trial. This…
Read More “Re-Consent for Participants Turning 18 in Pediatric Clinical Trials” »